PharmiWeb12h
Arthritic Therapeutic Market Poised to Surpass $136.1+ Billion Globally by 2032, Fueled by a 5.5% CAGR
According to a recent report from Allied Market Research titled “Arthritic Therapeutic Market by Product Type (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs ...
PharmiWeb12h
Breathing New Life: Emphysema Treatment Market Projected to Reach $8.7 Billion Worldwide by 2032, Driven by 3.3% Annual Growth
Discover the latest insights into the Emphysema Treatment Market with Allied Market Research’s comprehensive report. Valued at $6.3 billion in 2022, the market is projected to reach $8.7 billion by ...
PharmiWeb12h
Life Science IT Market Projected to Exceed $62.4 Billion by 2032, Sustaining 11% CAGR Growth
Life science IT solutions encompass a diverse array of technological innovations aimed at optimizing and simplifying numerous facets of research, development, and healthcare within the life sciences ...
PharmiWeb12h
Anthelmintic Drugs Market to Surpass $1.5+ Billion by 2032, Driven by 3.8% CAGR
According to a report by Allied Market Research titled “Anthelmintic Drugs Market,” the global market for anthelmintic drugs is categorized by drug class into Benzimidazoles, Macrocyclic Lactones, ...
PharmiWeb14h
Vaccine Adjuvants Market Size to Surpass USD 1.5 Billion by 2032, Exhibiting a CAGR of 4%
Allied Market Research published a report, titled, “Vaccine Adjuvants Market by Product Type (Immunostimulants and Vehicles & Mucosal Adjuvants), Disease (Infectious Diseases and Cancer), and ...
PharmiWeb14h
Empty Capsules Market Size to Surpass USD 5.23 Billion by 2030, Exhibiting a CAGR of 8.1%
Allied Market Research published a report, titled, “Empty Capsules Market by Product (Gelatin Capsules and Non-Gelatin Capsules), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl ...
PharmiWeb14h
Monoclonal Antibodies Market Size to Surpass USD 390.58 Billion by 2030, Exhibiting a CAGR of 10.2%
Allied Market Research published a report, titled, “Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, and Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, ...
PharmiWeb14h
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab
SynOx is developing emactuzumab - a potential best-in-class, next-generation CSF1(R) inhibiting monoclonal antibodyProvides flexible loan facility to support additional clinical work and activities to ...
PharmiWeb14h
Elekta further strengthens its Elekta ONE software suite with acquisition of Philips treatment planning patent portfolio
STOCKHOLM – Elekta (EKTA-B.ST) announces the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent portfolio. This strategic move bolsters Elekta’s position in treatment ...
PharmiWeb13h
Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
NORTHAMPTON, MA / ACCESSWIRE / May 3, 2024 / Gilead SciencesForbes has listed Gilead as one of America's Best Employers for Diversity. We believe that by championing inclusion and diversity, we not ...
PharmiWeb17h
Nasal Cannula Market Expected to Expand at 6.3% CAGR, Reaching USD 14.6 Billion by 2033
According to a recent report by Market.us, the Global Nasal Cannula Market size is expected to be worth around USD 14.6 Billion by 2033 from USD 7.9 Billion in 2023, growing at a CAGR of 6.3% during ...
PharmiWeb16h
Lateral Flow Assays Market Anticipated to Reach $13.4 Billion by 2030, Fueled by a 4.70% Compound Annual Growth Rate
In the dynamic landscape of healthcare diagnostics, lateral flow assays have emerged as a pivotal technology, revolutionizing point-of-care testing. A recent report sheds light on the remarkable ...